Suppr超能文献

心脏-肾脏联合移植的生存获益不仅限于依赖透析的患者。

The survival benefit of simultaneous heart-kidney transplantation extends beyond dialysis-dependent patients.

作者信息

Kilic Arman, Grimm Joshua C, Whitman Glenn J R, Shah Ashish S, Mandal Kaushik, Conte John V, Sciortino Christopher M

机构信息

Division of Cardiac Surgery, The Johns Hopkins Hospital, Baltimore, Maryland.

Division of Cardiac Surgery, The Johns Hopkins Hospital, Baltimore, Maryland.

出版信息

Ann Thorac Surg. 2015 Apr;99(4):1321-7. doi: 10.1016/j.athoracsur.2014.09.026. Epub 2015 Feb 21.

Abstract

BACKGROUND

This study evaluated the effect of simultaneous heart-kidney transplantation (SHK) on survival stratified by preoperative renal function.

METHODS

Patients undergoing SHK or heart transplant alone (HTA) between 1992 and 2012 were identified in the United Network for Organ Sharing database. Patients were primarily stratified by the need for dialysis before transplantation. Nondialysis patients were further stratified by preoperative glomerular filtration rate (GFR) and likelihood of postoperative development of renal failure requiring new-onset dialysis (high risk defined as ≥75th percentile according to a previously derived and validated risk score). The primary outcome was 5-year survival, evaluated by Kaplan-Meier and multivariable logistic regression analyses.

RESULTS

Included were 665 (2%) SHK and 38,488 (98%) HTA patients. SHK improved 5-year survival in dialysis-dependent patients (69% vs 54%, p < 0.001), with no survival difference in patients with a preoperative GFR ≥60 mL/min/1.73 m(2) (84% SHK vs 77% HTA, p = 0.34). In patients with a preoperative GFR of less than 60 mL/min/1.73 m(2), being high risk for postoperative new-onset dialysis discriminated those patients who would benefit from SHK (5-year survival low risk: 82% SHK vs 76% HTA, p = 0.27; 5-year survival high risk: 86% SHK vs 67% HTA, p < 0.001). Risk-adjusted analysis confirmed these findings. SHK comprised only 2.6% of heart transplants in patients with a preoperative GFR of less than 60 mL/min/1.73 m(2) who were at high risk for postoperative renal failure.

CONCLUSIONS

SHK improves long-term survival not only in dialysis-dependent patients but also in patients with reduced preoperative GFR who are at high risk for postoperative new-onset dialysis. Expansion of SHK into this subset warrants further study, especially considering its low current utilization.

摘要

背景

本研究评估了同期心肾联合移植(SHK)对根据术前肾功能分层的生存率的影响。

方法

在器官共享联合网络数据库中识别出1992年至2012年间接受SHK或单纯心脏移植(HTA)的患者。患者主要根据移植前是否需要透析进行分层。非透析患者进一步根据术前肾小球滤过率(GFR)和术后发生需要新透析的肾衰竭的可能性进行分层(高风险定义为根据先前推导并验证的风险评分处于第75百分位数及以上)。主要结局是5年生存率,通过Kaplan-Meier和多变量逻辑回归分析进行评估。

结果

纳入665例(2%)SHK患者和38488例(98%)HTA患者。SHK提高了依赖透析患者的5年生存率(69%对54%,p<0.001),术前GFR≥60 mL/min/1.73 m²的患者生存率无差异(SHK为84%,HTA为77%,p = 0.34)。在术前GFR低于60 mL/min/1.73 m²的患者中,术后新发透析高风险可区分出那些将从SHK中获益的患者(5年生存率低风险:SHK为82%,HTA为76%,p = 0.27;5年生存率高风险:SHK为86%,HTA为67%,p<0.001)。风险调整分析证实了这些发现。在术前GFR低于60 mL/min/1.73 m²且术后肾衰竭高风险的患者中,SHK仅占心脏移植的2.6%。

结论

SHK不仅提高了依赖透析患者的长期生存率,还提高了术前GFR降低且术后新发透析高风险患者的长期生存率。将SHK扩展到这一亚组值得进一步研究,特别是考虑到其目前的低利用率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验